Detalhe da pesquisa
1.
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy.
Blood
; 142(24): 2079-2091, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595362
2.
MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis.
FASEB J
; 36(8): e22449, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839070
3.
Molecular and epigenetic alterations in normal and malignant myelopoiesis in human leukemia 60 (HL60) promyelocytic cell line model.
Front Cell Dev Biol
; 11: 1060537, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819104
4.
Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approach.
PLoS One
; 17(3): e0264400, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263357
5.
Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.
Front Oncol
; 9: 692, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31448224
6.
SMARCD1 negatively regulates myeloid differentiation of leukemic cells via epigenetic mechanisms.
Blood Adv
; 6(10): 3106-3113, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078226